Squarepoint’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$91.9M Buy
1,672,447
+283,719
+20% +$15.6M 0.1% 115
2025
Q1
$98.2M Buy
1,388,728
+695,590
+100% +$49.2M 0.12% 80
2024
Q4
$45.6M Buy
693,138
+488,612
+239% +$32.1M 0.04% 181
2024
Q3
$14.4M Buy
204,526
+100,841
+97% +$7.09M 0.02% 387
2024
Q2
$8.54M Sell
103,685
-757,532
-88% -$62.4M 0.01% 511
2024
Q1
$75.2M Buy
861,217
+582,506
+209% +$50.9M 0.13% 64
2023
Q4
$26.9M Sell
278,711
-177,477
-39% -$17.1M 0.05% 207
2023
Q3
$40.4M Buy
456,188
+138,897
+44% +$12.3M 0.1% 129
2023
Q2
$27.5M Buy
317,291
+145,932
+85% +$12.6M 0.08% 159
2023
Q1
$16.7M Sell
171,359
-3,774
-2% -$367K 0.07% 205
2022
Q4
$18.1M Buy
175,133
+151,541
+642% +$15.7M 0.07% 179
2022
Q3
$2M Buy
+23,592
New +$2M 0.01% 786
2022
Q2
Sell
-218,758
Closed -$16.9M 2149
2022
Q1
$16.9M Sell
218,758
-38,713
-15% -$2.98M 0.07% 203
2021
Q4
$22.7M Buy
257,471
+60,156
+30% +$5.31M 0.06% 160
2021
Q3
$15.3M Buy
197,315
+108,567
+122% +$8.39M 0.04% 205
2021
Q2
$7.41M Sell
88,748
-37,305
-30% -$3.11M 0.03% 364
2021
Q1
$9.52M Buy
126,053
+68,303
+118% +$5.16M 0.06% 250
2020
Q4
$5.06M Buy
57,750
+31,884
+123% +$2.8M 0.04% 390
2020
Q3
$1.97M Sell
25,866
-43,736
-63% -$3.33M 0.03% 631
2020
Q2
$8.59M Sell
69,602
-51,583
-43% -$6.36M 0.14% 206
2020
Q1
$10.2M Sell
121,185
-241,492
-67% -$20.4M 0.26% 77
2019
Q4
$30.7M Buy
362,677
+301,244
+490% +$25.5M 0.18% 89
2019
Q3
$4.14M Sell
61,433
-58,184
-49% -$3.92M 0.04% 525
2019
Q2
$10.2M Buy
119,617
+13,582
+13% +$1.16M 0.1% 245
2019
Q1
$9.42M Buy
106,035
+101,802
+2,405% +$9.04M 0.1% 246
2018
Q4
$360K Buy
+4,233
New +$360K ﹤0.01% 1396
2017
Q4
Sell
-55,529
Closed -$5.17M 2080
2017
Q3
$5.17M Buy
+55,529
New +$5.17M 0.1% 260
2016
Q4
Sell
-2,800
Closed -$259K 1768
2016
Q3
$259K Sell
2,800
-8,327
-75% -$770K 0.02% 792
2016
Q2
$866K Buy
+11,127
New +$866K 0.05% 393
2016
Q1
Sell
-6,800
Closed -$712K 1179
2015
Q4
$712K Sell
6,800
-798
-11% -$83.6K 0.08% 368
2015
Q3
$800K Buy
+7,598
New +$800K 0.2% 139
2015
Q2
Sell
-7,200
Closed -$897K 469
2015
Q1
$897K Buy
+7,200
New +$897K 0.31% 104